TWD 55.6
(-3.47%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.10 TWD | -93.33% |
2022 | 1.50 TWD | 2.74% |
2021 | 1.46 TWD | 37.74% |
2020 | 1.06 TWD | -42.7% |
2019 | 1.85 TWD | -17.04% |
2018 | 2.23 TWD | -11.51% |
2017 | 2.52 TWD | -10.64% |
2016 | 2.82 TWD | 47.64% |
2015 | 1.91 TWD | 56.56% |
2014 | 1.22 TWD | -40.49% |
2013 | 2.05 TWD | 173.33% |
2012 | 0.75 TWD | -81.3% |
2011 | 4.01 TWD | 8.67% |
2010 | 3.69 TWD | 6.96% |
2009 | 3.45 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.59 TWD | -612.56% |
2024 Q1 | -0.08 TWD | -143.58% |
2023 Q3 | -0.17 TWD | -200.0% |
2023 FY | - TWD | -93.33% |
2023 Q1 | -0.08 TWD | -118.24% |
2023 Q4 | 0.19 TWD | 211.76% |
2023 Q2 | 0.17 TWD | 302.62% |
2022 Q2 | 0.65 TWD | 182.61% |
2022 FY | - TWD | 2.74% |
2022 Q1 | 0.23 TWD | -55.77% |
2022 Q3 | 0.17 TWD | -73.85% |
2022 Q4 | 0.46 TWD | 170.59% |
2021 Q4 | 0.52 TWD | 1.96% |
2021 FY | - TWD | 37.74% |
2021 Q1 | 0.20 TWD | -73.68% |
2021 Q2 | 0.22 TWD | 10.0% |
2021 Q3 | 0.51 TWD | 131.82% |
2020 Q1 | -0.14 TWD | -114.74% |
2020 Q2 | -0.26 TWD | -85.71% |
2020 Q3 | 0.68 TWD | 361.54% |
2020 FY | - TWD | -42.7% |
2020 Q4 | 0.76 TWD | 11.76% |
2019 FY | - TWD | -17.04% |
2019 Q1 | 0.12 TWD | -88.79% |
2019 Q2 | 0.67 TWD | 458.33% |
2019 Q3 | 0.10 TWD | -85.07% |
2019 Q4 | 0.95 TWD | 850.0% |
2018 FY | - TWD | -11.51% |
2018 Q4 | 1.07 TWD | 137.78% |
2018 Q3 | 0.45 TWD | -4.26% |
2018 Q2 | 0.47 TWD | 95.83% |
2018 Q1 | 0.24 TWD | -70.73% |
2017 Q4 | 0.82 TWD | 0.0% |
2017 Q3 | 0.82 TWD | 67.35% |
2017 FY | - TWD | -10.64% |
2017 Q2 | 0.49 TWD | 19.51% |
2017 Q1 | 0.41 TWD | -64.04% |
2016 FY | - TWD | 47.64% |
2016 Q4 | 1.14 TWD | 32.56% |
2016 Q3 | 0.86 TWD | 36.51% |
2016 Q2 | 0.63 TWD | 215.0% |
2016 Q1 | 0.20 TWD | -71.83% |
2015 FY | - TWD | 56.56% |
2015 Q3 | 0.59 TWD | 145.83% |
2015 Q4 | 0.71 TWD | 20.34% |
2015 Q2 | 0.24 TWD | -38.46% |
2015 Q1 | 0.39 TWD | -54.12% |
2014 Q4 | 0.85 TWD | 254.17% |
2014 Q1 | 0.06 TWD | -57.14% |
2014 Q2 | 0.05 TWD | -16.67% |
2014 FY | - TWD | -40.49% |
2014 Q3 | 0.24 TWD | 380.0% |
2013 Q3 | 0.70 TWD | -2.78% |
2013 Q1 | 0.45 TWD | 164.71% |
2013 FY | - TWD | 173.33% |
2013 Q4 | 0.14 TWD | -80.0% |
2013 Q2 | 0.72 TWD | 60.0% |
2012 Q1 | 0.00 TWD | -99.78% |
2012 Q4 | 0.17 TWD | -68.52% |
2012 Q3 | 0.54 TWD | 1730.51% |
2012 Q2 | 0.03 TWD | 953.57% |
2012 FY | - TWD | -81.3% |
2011 Q1 | 0.99 TWD | 17.86% |
2011 FY | - TWD | 8.67% |
2011 Q4 | 1.30 TWD | 44.44% |
2011 Q3 | 0.90 TWD | 0.0% |
2011 Q2 | 0.90 TWD | -9.09% |
2010 Q4 | 0.84 TWD | -9.68% |
2010 Q2 | 0.88 TWD | 60.0% |
2010 Q3 | 0.93 TWD | 5.68% |
2010 Q1 | 0.55 TWD | 0.0% |
2010 FY | - TWD | 6.96% |
2009 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 1.96 TWD | 94.898% |
Maxigen Biotech Inc. | 1.86 TWD | 94.624% |
SciVision Biotech Inc. | 2.66 TWD | 96.241% |
Pegavision Corporation | 22.83 TWD | 99.562% |
Visco Vision Inc. | 4.79 TWD | 97.912% |